PSUSA/00002139/202411
Submitted by Anonymous (not verified) on 17 July 2025 - 11:00
PSUSA/00002139/202411
PSUSA/00002036/202411
Submitted by Anonymous (not verified) on 17 July 2025 - 10:45
PSUSA/00002036/202411
PSUSA/00002011/202412
Submitted by Anonymous (not verified) on 17 July 2025 - 10:38
PSUSA/00002011/202412
Timetable: Annual reassessment
Submitted by Anonymous (not verified) on 17 July 2025 - 9:30
Timetable: Annual reassessment
Timetable: Marketing authorisation renewal application
Submitted by Anonymous (not verified) on 17 July 2025 - 8:57
Timetable: Marketing authorisation renewal application
PSUSA/00010270/202411
Submitted by Anonymous (not verified) on 17 July 2025 - 8:06
PSUSA/00010270/202411
Human medicines European public assessment report (EPAR): Sugammadex Mylan, sugammadex, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 16 July 2025 - 16:45
Human medicines European public assessment report (EPAR): Sugammadex Mylan, sugammadex, Date of authorisation: 15/11/2021, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Javlor, vinflunine, Date of authorisation: 21/09/2009, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 16 July 2025 - 16:01
Human medicines European public assessment report (EPAR): Javlor, vinflunine, Date of authorisation: 21/09/2009, Revision: 12, Status: Authorised
Scientific and technical recommendations: Veterinary Medicines Regulation
Submitted by Anonymous (not verified) on 16 July 2025 - 15:59
Scientific and technical recommendations: Veterinary Medicines Regulation
Guide to information on human medicines evaluated by European Medicines Agency: what the Agency publishes and when
Submitted by Anonymous (not verified) on 16 July 2025 - 13:26
Guide to information on human medicines evaluated by European Medicines Agency: what the Agency publishes and when